Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Acta Vet. Brasilica ; 16(1): 58-64, jan. 2022. ilus, tab
Artigo em Inglês | VETINDEX | ID: biblio-1437525

RESUMO

Urinary tract infections are commonly diagnosed in dogs, accounting for 2 to 3% of cases in the clinical routine, as cystitis being the most reported condition. Dogs of all ages and breeds can be affected, and early diagnosis is an important tool for therapeutic success. Urine culture and antibiogram are gold-standard tests for the diagnosis of bacterial cystitis, allowing correct therapy and better recovery of the patient, since currently there is great resistance to antimicrobials used in the veterinary clinics. Thus, the aim of this study was to determine the main etiological agents isolated in dog urine cultures, as well as the resistance and sensitivity profile of the isolated agents in relation to antibiotics, in order to assist the clinician ́s choice of the most appropriate antimicrobial, aiming at the patient's therapeutic success. For this study, a retrospective study was performed of 49 samples of urine cultures of male and female dogs, collected between 2012 and 2021, which were positive for bacterial growth. From this analysis, it was observed that Escherichia coli, Enterococcus spp. and Staphylococcus spp. were the most isolated agents, presenting higher antimicrobial resistance to cephalexin, sulfadiazine plus trimethoprim, ampicillin, enrofloxacin and ciprofloxacin, respectively.(AU)


s infecções do trato urinário são comumente diagnosticadas em cães, representando de 2 a 3% dos casos na rotina clínica, sendo a cistite a afecção mais relatada. Cães de todas as idades e raças podem ser acometidos, sendo o diagnóstico precoce uma ferramenta importante para o sucesso terapêutico. A urocultura e o antibiograma são exames padrão-ouro para o diagnóstico das cistites bacterianas, permitindo a terapêutica correta e melhor recuperação do paciente, já que atualmente há grande resistência aos antimicrobianos empregados na rotina clínica veterinária. Desta forma, o objetivo deste estudo foi determinar os principais agentes etiológicos isolados nas uroculturas de cães, bem como o perfil de resistência e sensibilidade dos agentes isolados frente aos antibióticos, de modo a auxiliar o médico veterinário na eleição do antimicrobiano mais adequado, visando sucesso terapêutico do paciente. Para realização deste estudo foi feita uma análise retrospectiva de 49 uroculturas de cães machos e fêmeas, coletadas entre os anos de 2012 e 2021, as quais apresentaram crescimento bacteriano positivo. A partir desta análise foi observado que Escherichia coli, Enterococcus spp. e Staphylococcus spp. foram os agentes mais isolados nas uroculturas, apresentando maior resis-tência aos antimicrobianos cefalexina, sulfazotrim ampicilina, enrofloxacina e ciprofloxacina, respectivamente.(AU)


Assuntos
Animais , Sistema Urinário/microbiologia , Cistite/diagnóstico , Cães , Infecções por Escherichia coli/diagnóstico , Fenômenos Fisiológicos Bacterianos , Escherichia coli/imunologia , Anti-Infecciosos/urina
2.
Clin Drug Investig ; 26(6): 323-8, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-17163266

RESUMO

BACKGROUND: and objective: In Mexico, urinary tract infections (UTIs) constitute the second most frequent type of infections treated at primary-care clinics. Ciprofloxacin has played a major role in the treatment of UTIs because it has a broad spectrum of antibacterial activity. In addition to antimicrobial agents, phenazopyridine has been used to alleviate symptoms that occur during episodes of UTI. Thus, the present study was designed to compare the pharmacokinetic behaviour of ciprofloxacin administered alone versus ciprofloxacin combined with phenazopyridine. PATIENTS AND METHODS: Twenty-four healthy male Mexican volunteers participated in this project. The study was carried out with a single oral dose of ciprofloxacin 500mg. The double-blind, crossover, randomised, balanced trial design comprised two treatments, two periods and two sequences. After administration of the study medication, serial blood samples were collected for a period of 12 hours. The harvested plasma was analysed for ciprofloxacin by high-performance liquid chromatography. The area under the concentration-time curve to last measurable concentration (AUC(t)), area under the concentration-time curve extrapolated to infinity (AUC(infinity)), peak plasma concentration (C(max)), time to reach C(max) (t(max)), mean residence time (MRT), elimination constant (k(e)) and elimination half-life (t(1/2)) were determined from plasma concentrations of both treatments and considered as primary variables for statistical analysis. RESULTS: While there were no differences between the two treatments in terms of C(max) and k(e), AUC(t )and AUC(infinity) were 35% and 29% higher, respectively, in the combined treatment arm. Moreover, a significant delay in t(max )(from 1 to 1.5 hours) and a statistical increase of 29% in MRT were also observed with phenazopyridine co-administration. CONCLUSION: Oral co-administration of phenazopyridine increases ciprofloxacin bioavailability with regard to the amount absorbed (AUC) and permanence in the body (MRT), which could be useful during treatment.


Assuntos
Ciprofloxacina/farmacocinética , Fenazopiridina/farmacocinética , Administração Oral , Adulto , Anestésicos Locais/farmacocinética , Anestésicos Locais/urina , Anti-Infecciosos/sangue , Anti-Infecciosos/farmacocinética , Anti-Infecciosos/urina , Área Sob a Curva , Disponibilidade Biológica , Cromatografia Líquida de Alta Pressão , Ciprofloxacina/administração & dosagem , Ciprofloxacina/efeitos adversos , Estudos Cross-Over , Método Duplo-Cego , Combinação de Medicamentos , Interações Medicamentosas , Meia-Vida , Humanos , Masculino , Taxa de Depuração Metabólica , México , Náusea/induzido quimicamente , Fenazopiridina/administração & dosagem , Fenazopiridina/efeitos adversos , Comprimidos , Fatores de Tempo
3.
J Chromatogr B Biomed Sci Appl ; 698(1-2): 312-6, 1997 Sep 26.
Artigo em Inglês | MEDLINE | ID: mdl-9836853

RESUMO

A sensitive gas chromatographic method for the quantitative determination of the new antibacterial and antifungal drug G1, 1-(5-bromofuran-2-yl)-2-bromo-2-nitroethene, has been optimized. The method involves a fast and single extraction step from spiked serum and urine samples. The G1 drug was quantified using an internal standard method and by means of a nitrogen-selective detector. The results are statistically significant and show that mean levels of G1 as low as 1 microg ml(-1) can be measured accurately.


Assuntos
Anti-Infecciosos/análise , Antifúngicos/análise , Antineoplásicos/análise , Cromatografia Gasosa/métodos , Furanos/análise , Nitrocompostos/análise , Anti-Infecciosos/sangue , Anti-Infecciosos/urina , Antifúngicos/sangue , Antifúngicos/urina , Antineoplásicos/sangue , Antineoplásicos/urina , Furanos/sangue , Furanos/urina , Nitrocompostos/sangue , Nitrocompostos/urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA